CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase · Pre-funded Warrants to Purchase Common Stock | +165,950 | 165,950 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase · Warrants to Purchase Common Stock | +3,084,090 | 3,084,090 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase · Warrants to Purchase Common Stock | +2,446,209 | 2,446,209 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase · Warrants to Purchase Common Stock | +252,291 | 252,291 | ||
| 2023-05-01 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +179,000 | 179,000 | ||
| 2023-05-01 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +317,147 | 317,147 | ||
| 2023-05-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Common Stock (right to buy) | +383,299 | 383,299 | ||
| 2023-05-01 | Ogier Walter C Director | Grant or award · Stock Option (right to buy) | +150,437 | 150,437 | ||
| 2023-05-01 | Little Paul Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +198,126 | 198,126 | ||
| 2023-05-01 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +752,185 | 752,185 | ||
| 2023-05-01 | McBride John S. Director | Grant or award · Stock Option (right to buy) | +150,437 | 150,437 | ||
| 2023-05-01 | LYONS GARY A Director | Grant or award · Common Stock | +150,437 | 150,437 | ||
| 2023-05-01 | Lee June Director | Grant or award · Stock Option (right to buy) | +150,437 | 150,437 | ||
| 2023-05-01 | Hillson Jan Director | Grant or award · Stock Option (right to buy) | +150,437 | 150,437 | ||
| 2023-02-01 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2023-02-01 | Ogier Walter C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-02-01 | McBride John S. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-02-01 | LYONS GARY A Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-02-01 | Lee June Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-02-01 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 4 of 15 · 300 trades